Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John G Gums

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
Scientific Reports|November 24, 2017
Whole Transcriptome Sequencing Analyses Reveal Molecular Markers of Blood Pressure Response to Thiazide DiureticsAna Caroline C Sá, Amy Webb, Yan Gong, et al.
Circulation. Cardiovascular Genetics|January 25, 2017
Genome-Wide Prioritization and Transcriptomics Reveal Novel Signatures Associated With Thiazide Diuretics Blood Pressure ResponseMohamed H Shahin, Ana C Sá, Amy Webb, et al.
Hypertension (Dallas, Tex. : 1979)|January 6, 2016
Pharmacogenomic Genome-Wide Meta-Analysis of Blood Pressure Response to β-Blockers in Hypertensive African AmericansYan Gong, Zhiying Wang, Amber L Beitelshees, et al.
BMC Medical Genomics|June 22, 2018
Blood pressure signature genes and blood pressure response to thiazide diuretics: results from the PEAR and PEAR-2 studiesAna Caroline C Sá, Amy Webb, Yan Gong, et al.
Journal of the American Heart Association|December 31, 2017
Sphingolipid Metabolic Pathway Impacts Thiazide Diuretics Blood Pressure Response: Insights From Genomics, Metabolomics, and LipidomicsMohamed H Shahin, Yan Gong, Reginald F Frye, et al.
Hypertension (Dallas, Tex. : 1979)|September 6, 2012
G protein receptor kinase 4 polymorphisms: β-blocker pharmacogenetics and treatment-related outcomes in hypertensionAlexander G Vandell, Maximilian T Lobmeyer, Brian E Gawronski, et al.
Hypertension (Dallas, Tex. : 1979)|July 7, 2016
A Genetic Response Score for Hydrochlorothiazide Use: Insights From Genomics and Metabolomics IntegrationMohamed H Shahin, Yan Gong, Caitrin W McDonough, et al.
Journal of the American Heart Association|January 28, 2015
Pharmacogenomics of hypertension: a genome‐wide, placebo‐controlled cross‐over study, using four classes of antihypertensive drugsTimo P Hiltunen, Kati M Donner, Antti-Pekka Sarin, et al.
Circulation. Cardiovascular Genetics|March 15, 2014
Is diabetes mellitus-linked amino acid signature associated with β-blocker-induced impaired fasting glucose?Rhonda M Cooper-Dehoff, Wei Hou, Liming Weng, et al.
Journal of Clinical Medicine|July 26, 2020
Design and Early Implementation Successes and Challenges of a Pharmacogenetics Consult ClinicMeghan J Arwood, Eric A Dietrich, Benjamin Q Duong, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Scientific Reports|November 24, 2017
Whole Transcriptome Sequencing Analyses Reveal Molecular Markers of Blood Pressure Response to Thiazide DiureticsAna Caroline C Sá, Amy Webb, Yan Gong, et al.
Circulation. Cardiovascular Genetics|January 25, 2017
Genome-Wide Prioritization and Transcriptomics Reveal Novel Signatures Associated With Thiazide Diuretics Blood Pressure ResponseMohamed H Shahin, Ana C Sá, Amy Webb, et al.
Hypertension (Dallas, Tex. : 1979)|January 6, 2016
Pharmacogenomic Genome-Wide Meta-Analysis of Blood Pressure Response to β-Blockers in Hypertensive African AmericansYan Gong, Zhiying Wang, Amber L Beitelshees, et al.
BMC Medical Genomics|June 22, 2018
Blood pressure signature genes and blood pressure response to thiazide diuretics: results from the PEAR and PEAR-2 studiesAna Caroline C Sá, Amy Webb, Yan Gong, et al.
Journal of the American Heart Association|December 31, 2017
Sphingolipid Metabolic Pathway Impacts Thiazide Diuretics Blood Pressure Response: Insights From Genomics, Metabolomics, and LipidomicsMohamed H Shahin, Yan Gong, Reginald F Frye, et al.
Hypertension (Dallas, Tex. : 1979)|September 6, 2012
G protein receptor kinase 4 polymorphisms: β-blocker pharmacogenetics and treatment-related outcomes in hypertensionAlexander G Vandell, Maximilian T Lobmeyer, Brian E Gawronski, et al.
Hypertension (Dallas, Tex. : 1979)|July 7, 2016
A Genetic Response Score for Hydrochlorothiazide Use: Insights From Genomics and Metabolomics IntegrationMohamed H Shahin, Yan Gong, Caitrin W McDonough, et al.
Journal of the American Heart Association|January 28, 2015
Pharmacogenomics of hypertension: a genome‐wide, placebo‐controlled cross‐over study, using four classes of antihypertensive drugsTimo P Hiltunen, Kati M Donner, Antti-Pekka Sarin, et al.
Circulation. Cardiovascular Genetics|March 15, 2014
Is diabetes mellitus-linked amino acid signature associated with β-blocker-induced impaired fasting glucose?Rhonda M Cooper-Dehoff, Wei Hou, Liming Weng, et al.
Journal of Clinical Medicine|July 26, 2020
Design and Early Implementation Successes and Challenges of a Pharmacogenetics Consult ClinicMeghan J Arwood, Eric A Dietrich, Benjamin Q Duong, et al.
Pageof 10